Predicting drug–drug interactions in breast cancer patients treated with CDK4/6 inhibitors and forward planning
Article in Expert Opinion on Drug Metabolism & Toxicology (April 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety
Article in Seminars in Oncology (December 2023)
Ribociclib may potentiate rosuvastatin effect in causing late onset rhabdomyolysis
Article in BMJ Case Reports (September 2023)